# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
CellProthera's clinical results from the Phase I/IIb EXCELLENT Trial, which studied the feasibility of transendocardial inj...
On Friday before the market open, BioCardia announced it received approval from the United States Patent Office for its applic...
GME: -16% | GameStop shares are trading lower after the company released worse-than-expected Q1 results before schedule and fil...